Pfizer (NYSE:PFE) Given “Buy” Rating at Truist Financial
Truist Financial reiterated their buy rating on shares of Pfizer (NYSE:PFE – Free Report) in a research note published on Monday morning, Benzinga reports. Truist Financial currently has a $42.00 price objective on the biopharmaceutical company’s stock. Other equities analysts have also issued research reports about the company. Cantor Fitzgerald reaffirmed an overweight rating and […]
More Stories
McDonald’s Co. (NYSE:MCD) Shares Purchased by ARS Wealth Advisors Group LLC
ARS Wealth Advisors Group LLC increased its position in McDonald’s Co. (NYSE:MCD – Free Report) by 19.6% during the fourth...
Bouygues SA (OTCMKTS:BOUYY) Short Interest Up 483.7% in December
Bouygues SA (OTCMKTS:BOUYY – Get Free Report) was the recipient of a large growth in short interest in the month...
QUALCOMM Incorporated (NASDAQ:QCOM) Shares Purchased by Burney Co.
Burney Co. raised its stake in shares of QUALCOMM Incorporated (NASDAQ:QCOM – Free Report) by 665.6% during the fourth quarter,...
Advanced Micro Devices (NASDAQ:AMD) Shares Up 2.1% – Here’s What Happened
Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD – Get Free Report) shot up 2.1% during trading on Wednesday . The...
Puerto Rico Governor Asks Trump for Help After Venezuela’s Maduro Issues Threat
By Jack Phillips The governor of Puerto Rico asked President-elect Donald Trump for assistance following threats made by Venezuelan President...
BSR Real Estate Investment Trust (OTCMKTS:BSRTF) Short Interest Update
BSR Real Estate Investment Trust (OTCMKTS:BSRTF – Get Free Report) was the target of a large increase in short interest...